1. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Issue 8 (August 2022) Authors: Zhu, Fengcai; Zhuang, Chunlan; Chu, Kai; Zhang, Liang; Zhao, Hui; Huang, Shoujie; Su, Yingying; Lin, Hongyan; Yang, Changlin; Jiang, Hanmin; Zang, Xia; Liu, Donglin; Pan, Hongxing; Hu, Yuemei; Liu, Xiaohui; Chen, Qi; Song, Qiaoqiao; Quan, Jiali; Huang, Zehong; Zhong, Guohua Journal: Lancet Issue: Volume 10:Issue 8(2022) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗